The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Tuberculosis, Multidrug-Resistant

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Tuberculosis, Multidrug-Resistant


High impact information on Tuberculosis, Multidrug-Resistant


Chemical compound and disease context of Tuberculosis, Multidrug-Resistant


Biological context of Tuberculosis, Multidrug-Resistant


Anatomical context of Tuberculosis, Multidrug-Resistant

  • Ten patients with MDR tuberculosis also were treated with imipenem in combination with other first- or second-line agents; elimination of M. tuberculosis from sputum samples was measured by quantitative culture [15].

Gene context of Tuberculosis, Multidrug-Resistant


Analytical, diagnostic and therapeutic context of Tuberculosis, Multidrug-Resistant


  1. Allele-specific rpoB PCR assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears. Mokrousov, I., Otten, T., Vyshnevskiy, B., Narvskaya, O. Antimicrob. Agents Chemother. (2003) [Pubmed]
  2. Current and future clinical applications of interferon-gamma in host antimicrobial defense. Murray, H.W. Intensive care medicine. (1996) [Pubmed]
  3. Partial intestinal obstruction due to clofazimine in a patient with multidrug-resistant tuberculosis. Usküdar, O., Köksal, D., Köksal, A.S. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. (2005) [Pubmed]
  4. Cycloserine-induced Stevens-Johnson syndrome in an AIDS patient with multidrug-resistant tuberculosis. Akula, S.K., Aruna, A.S., Johnson, J.E., Anderson, D.S. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. (1997) [Pubmed]
  5. Kinetics and toxicity of liposomal and conventional amikacin in a patient with multidrug-resistant tuberculosis. Whitehead, T.C., Lovering, A.M., Cropley, I.M., Wade, P., Davidson, R.N. Eur. J. Clin. Microbiol. Infect. Dis. (1998) [Pubmed]
  6. Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing. Hewlett, D., Horn, D.L., Alfalla, C. JAMA (1995) [Pubmed]
  7. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. Beck-Sagué, C., Dooley, S.W., Hutton, M.D., Otten, J., Breeden, A., Crawford, J.T., Pitchenik, A.E., Woodley, C., Cauthen, G., Jarvis, W.R. JAMA (1992) [Pubmed]
  8. Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. DeBarber, A.E., Mdluli, K., Bosman, M., Bekker, L.G., Barry, C.E. Proc. Natl. Acad. Sci. U.S.A. (2000) [Pubmed]
  9. D-3-Phosphoglycerate dehydrogenase from Mycobacterium tuberculosis is a link between the Escherichia coli and mammalian enzymes. Dey, S., Hu, Z., Xu, X.L., Sacchettini, J.C., Grant, G.A. J. Biol. Chem. (2005) [Pubmed]
  10. Development of a suicide gene as a novel approach to killing Mycobacterium tuberculosis. Rom, W.N., Yie, T.A., Tchou-Wong, K.M. Am. J. Respir. Crit. Care Med. (1997) [Pubmed]
  11. Treatment and prevention of multidrug-resistant tuberculosis. Bastian, I., Colebunders, R. Drugs (1999) [Pubmed]
  12. Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance. Gumbo, T., Louie, A., Deziel, M.R., Drusano, G.L. Antimicrob. Agents Chemother. (2005) [Pubmed]
  13. Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood culture. Janulionis, E., Sofer, C., Song, H.Y., Wallis, R.S. Antimicrob. Agents Chemother. (2004) [Pubmed]
  14. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Maus, C.E., Plikaytis, B.B., Shinnick, T.M. Antimicrob. Agents Chemother. (2005) [Pubmed]
  15. Imipenem for treatment of tuberculosis in mice and humans. Chambers, H.F., Turner, J., Schecter, G.F., Kawamura, M., Hopewell, P.C. Antimicrob. Agents Chemother. (2005) [Pubmed]
  16. Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis. Victor, T.C., Warren, R., Butt, J.L., Jordaan, A.M., Felix, J.V., Venter, A., Sirgel, F.A., Schaaf, H.S., Donald, P.R., Richardson, M., Cynamon, M.H., Van Helden, P.D. J. Med. Microbiol. (1997) [Pubmed]
  17. Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru. Timperi, R., Han, L.L., Sloutsky, A., Becerra, M.C., Nardell, E.A., Salazar, J.J., Smith-Fawzi, M.C. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. (2005) [Pubmed]
  18. Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients. Condos, R., Raju, B., Canova, A., Zhao, B.Y., Weiden, M., Rom, W.N., Pine, R. Infect. Immun. (2003) [Pubmed]
  19. Recombinant human interleukin-2 reverses in vitro-deficient cell-mediated immune responses to tuberculin purified protein derivative by lymphocytes of tuberculous patients. Shiratsuchi, H., Okuda, Y., Tsuyuguchi, I. Infect. Immun. (1987) [Pubmed]
  20. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Aydin, I.O., Uluşahin, A. General hospital psychiatry. (2001) [Pubmed]
  21. SARS: just another viral acronym? Broxmeyer, L. Med. Hypotheses (2003) [Pubmed]
  22. Hypokalemia among patients receiving treatment for multidrug-resistant tuberculosis. Shin, S., Furin, J., Alcántara, F., Hyson, A., Joseph, K., Sánchez, E., Rich, M. Chest (2004) [Pubmed]
  23. Limited tolerability of levofloxacin and pyrazinamide for multidrug-resistant tuberculosis prophylaxis in a solid organ transplant population. Lou, H.X., Shullo, M.A., McKaveney, T.P. Pharmacotherapy (2002) [Pubmed]
  24. A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard retreatment regimen in Ho Chi Minh City, Vietnam. Lan NTN, n.u.l.l., Lademarco, M.F., Binkin, N.J., Tung, L.B., Quy, H.T., Cĵ, N.V. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. (2001) [Pubmed]
  25. Tuberculosis drug resistance and treatment outcomes under DOTS settings in large cities in the Philippines. Ohkado, A., Aguiman, L., Adlawan, S., Baring, E., Quirante, O., Suchi, M., Endo, S., Fujiki, A., Mori, T. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. (2006) [Pubmed]
WikiGenes - Universities